ADMA
NASDAQ · Biotechnology
Adma Biologics Inc
$9.90
-0.16 (-1.59%)
Analyst Consensus
Strong Buy
11
Analysts
Moderate
Coverage
Price Target
Analyst Price Target
+255.8% upside
Low Target
$21.76
Average Target
$35.22
High Target
$46.82
Current Price
$9.90
Current
$9.90
$9.90
Target
$35.22
$35.22
$21.76
$35.22 avg
$46.82
Scenario Analysis
Bear Case
$21.76
119.8%
Low target
Base Case
$35.22
+255.8%
Avg target
Bull Case
$46.82
+372.9%
High target
Risk/Reward
3.1x
Highly favorable
Price in Context
52-Week High
$20.46
-51.6% from high
52-Week Low
$7.21
+37.3% from low
50-Day SMA
$17.86
-44.6% vs SMA
200-Day SMA
$17.61
-43.8% vs SMA
RSI (14)
42.2
Neutral
Target vs 52W High
$35.22
+72.2% vs high
Next Earnings Report
Aug 12, 2026
2d
until earnings
EPS Est: $0.18
Earnings in 2 days. Analyst targets may shift significantly after the report.
Peer Consensus — Biotechnology
| Stock | Consensus | Analysts | Buy % | Target | Upside |
|---|---|---|---|---|---|
| ABBV | Strong Buy | 38 | 82% | $257.58 | +4.7% |
| AMGN | Hold | 43 | 49% | $190.87 | -53.6% |
| GILD | Strong Buy | 37 | 81% | $362.68 | +172.3% |
| VRTX | Strong Buy | 37 | 81% | $438.34 | -11.6% |
| REGN | Buy | 37 | 70% | $76.80 | -90.2% |
| NTRA | Strong Buy | 30 | 87% | $142.91 | -55.6% |
| RVMD | Strong Buy | 28 | 93% | $114.11 | -44.4% |
| BIIB | Buy | 43 | 67% | $91.45 | -56.0% |